IRWD Stock Summary

• Ironwood Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 3.27% of US listed stocks.
• IRWD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 4.56% of US stocks.
• As for revenue growth, note that IRWD's revenue has grown 39.54% over the past 12 months; that beats the revenue growth of 86.96% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Ironwood Pharmaceuticals Inc, a group of peers worth examining would be ERII, GH, MDB, ESTC, and ATEN.
• IRWD's SEC filings can be seen here. And to visit Ironwood Pharmaceuticals Inc's official web site, go to www.ironwoodpharma.com.